Using the hazard function to evaluate hepatocellular carcinoma recurrence risk after curative resection

被引:0
|
作者
Li, Wei-Feng [1 ,2 ]
Moi, Sin-Hua [3 ,4 ]
Liu, Yueh-Wei [1 ,2 ]
Yong, Chee-Chien [1 ,2 ]
Wang, Chih-Chi [1 ,2 ]
Yen, Yi-Hao [5 ,6 ]
Lin, Chih-Yun [7 ]
机构
[1] Kaohsiung Chang Gung Mem Hosp, Liver Transplantat Ctr, Ta Pei Rd, Kaohsiung 123, Taiwan
[2] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Ta Pei Rd, Kaohsiung 123, Taiwan
[3] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Res Ctr Precis Environm Med, Kaohsiung, Taiwan
[5] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Ta Pei Rd, Kaohsiung 123, Taiwan
[6] Chang Gung Univ, Coll Med, Ta Pei Rd, Kaohsiung 123, Taiwan
[7] Gung Mem Hosp, Biostat Ctr Kaohsiung Chang, Kaohsiung, Taiwan
关键词
Hepatocellular carcinoma; Liver resection; Recurrence; Hazard function; ATEZOLIZUMAB PLUS BEVACIZUMAB; SURGICAL RESECTION; CIRRHOSIS; THERAPY; LIVER; SCORE;
D O I
10.1007/s13304-023-01652-y
中图分类号
R61 [外科手术学];
学科分类号
摘要
Predicting recurrence patterns of hepatocellular carcinoma (HCC) can be helpful in developing surveillance strategies. This study aimed to use the hazard function to investigate recurrence hazard and peak recurrence time transitions in patients with HCC undergoing liver resection (LR). We enrolled 1204 patients with HCC undergoing LR between 2007 and 2018 at our institution. Recurrence hazard, patterns, and peak rates were analyzed. The overall recurrence hazard peaked at 7.2 months (peak hazard rate [pHR]: 0.0197), but varied markedly. In subgroups analysis based on recurrence risk factors, patients with a high radiographic tumor burden score (pHR: 0.0521), alpha-fetoprotein level >= 400 ng/ml (pHR: 0.0427), and pT3-4 (pHR: 0.0656) showed a pronounced peak within the first year after LR. Patients with cirrhosis showed a pronounced peak within three years after LR (pHR: 0.0248), whereas those with Barcelona Clinic Liver Cancer stage B (pHR: 0.0609) and poor tumor differentiation (pHR: 0.0451) showed multiple peaks during the 5-year follow-up period. In contrast, patients without these recurrence risk factors had a relatively flat hazard function curve. HCC recurrence hazard, patterns, and peak rates varied substantially depending on different risk factors of HCC recurrence.
引用
收藏
页码:2147 / 2155
页数:9
相关论文
共 50 条
  • [21] Analysis of the Risk Factors of Untransplantable Recurrence After Primary Curative Resection for Patients with Hepatocellular Carcinoma
    Ho, Cheng-Maw
    Wu, Chao-Ying
    Lee, Po-Huang
    Lai, Hong-Shiee
    Ho, Ming-Chih
    Wu, Yao-Ming
    Hu, Rey-Heng
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (08) : 2526 - 2533
  • [22] Influence of alcohol abuse on recurrence after curative resection of hepatocellular carcinoma
    Okada, S
    Ishii, H
    Nose, H
    Yoshimori, M
    Shimada, K
    Yamamoto, J
    Takayama, T
    Kosuge, T
    Yamasaki, S
    Sakamoto, M
    Hirohashi, S
    HEPATO-GASTROENTEROLOGY, 1995, 42 (06) : 944 - 949
  • [23] Recurrence after resection of hepatocellular carcinoma
    J-MRegimbeau
    J.Belghiti
    Hepatobiliary&PancreaticDiseasesInternational, 2002, (03) : 401 - 405
  • [24] Prognostic value of postoperative complication for early recurrence after curative resection of hepatocellular carcinoma
    Amisaki, Masataka
    Saito, Hiroaki
    Tokuyasu, Naruo
    Sakamoto, Teruhisa
    Honjo, Soichiro
    Fujiwara, Yoshiyuki
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2018, 17 (04) : 323 - 329
  • [25] Natural killer cell activity is a risk factor for the recurrence risk after curative treatment of hepatocellular carcinoma
    Lee, Han Ah
    Goh, Hyun Gil
    Lee, Young-Sun
    Jung, Young Kul
    Kim, Ji Hoon
    Yim, Hyung Joon
    Lee, Min-Goo
    An, Hyunggin
    Jeen, Yoon Tae
    Yeon, Jong Eun
    Byun, Kwan Soo
    Seo, Yeon Seok
    BMC GASTROENTEROLOGY, 2021, 21 (01)
  • [26] Prediction of Recurrence after Curative Resection of Hepatocellular Carcinoma using Liver Stiffness Measurement (FibroScanA®)
    Jung, Kyu Sik
    Kim, Seung Up
    Choi, Gi Hong
    Park, Jun Yong
    Park, Young Nyun
    Kim, Do Young
    Ahn, Sang Hoon
    Chon, Chae Yoon
    Kim, Kyung Sik
    Choi, Eun Hee
    Choi, Jin Sub
    Han, Kwang-Hyub
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (13) : 4278 - 4286
  • [27] Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma
    Shih-Yu Yang
    Chih-Chi Wang
    Kuang-Den Chen
    Yueh-Wei Liu
    Chih-Che Lin
    Ching-Hui Chuang
    Yu-Chieh Tsai
    Chih-Chien Yao
    Yi-Hao Yen
    Chang-Chun Hsiao
    Tsung-Hui Hu
    Ming-Chao Tsai
    BMC Cancer, 21
  • [28] Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma
    Yang, Shih-Yu
    Wang, Chih-Chi
    Chen, Kuang-Den
    Liu, Yueh-Wei
    Lin, Chih-Che
    Chuang, Ching-Hui
    Tsai, Yu-Chieh
    Yao, Chih-Chien
    Yen, Yi-Hao
    Hsiao, Chang-Chun
    Hu, Tsung-Hui
    Tsai, Ming-Chao
    BMC CANCER, 2021, 21 (01)
  • [29] Risk Factors for Early Recurrence of HBV-related Hepatocellular Carcinoma Meeting Milan Criteria after Curative Resection
    Zhu, Wen-Jiang
    Huang, Chu-Ying
    Li, Chuan
    Peng, Wei
    Wen, Tian-Fu
    Yan, Lv-Nan
    Li, Bo
    Wang, Wen-Tao
    Xu, Ming-Qing
    Yang, Jia-Yin
    Jiang, Li
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (12) : 7101 - 7106
  • [30] Prevention of recurrence after curative treatment for hepatocellular carcinoma
    Tsuyoshi Kobayashi
    Kohei Ishiyama
    Hideki Ohdan
    Surgery Today, 2013, 43 : 1347 - 1354